Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Shares Outstanding (Diluted Average): 2010-2025

Historic Shares Outstanding (Diluted Average) for Niagen Bioscience (NAGE) over the last 9 years, with Sep 2025 value amounting to $86.6 million.

  • Niagen Bioscience's Shares Outstanding (Diluted Average) rose 11.38% to $86.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.6 million, marking a year-over-year increase of 11.38%. This contributed to the annual value of $78.1 million for FY2024, which is 4.19% up from last year.
  • According to the latest figures from Q3 2025, Niagen Bioscience's Shares Outstanding (Diluted Average) is $86.6 million, which was up 0.44% from $86.2 million recorded in Q2 2025.
  • Niagen Bioscience's 5-year Shares Outstanding (Diluted Average) high stood at $86.6 million for Q3 2025, and its period low was $64.2 million during Q1 2021.
  • Over the past 3 years, Niagen Bioscience's median Shares Outstanding (Diluted Average) value was $75.6 million (recorded in 2024), while the average stood at $78.4 million.
  • Data for Niagen Bioscience's Shares Outstanding (Diluted Average) shows a peak YoY increased of 14.14% (in 2025) over the last 5 years.
  • Niagen Bioscience's Shares Outstanding (Diluted Average) (Quarterly) stood at $67.2 million in 2021, then grew by 3.79% to $69.7 million in 2022, then rose by 7.54% to $75.0 million in 2023, then climbed by 4.19% to $78.1 million in 2024, then rose by 11.38% to $86.6 million in 2025.
  • Its last three reported values are $86.6 million in Q3 2025, $86.2 million for Q2 2025, and $83.2 million during Q1 2025.